Using this path framework, and genetic variations in sex, TREM2 and APOE-ε4 as instrumental variables we can infer how different biological processes influence the AD cascade leading to increases in discrete stages of tau pathology (i.e., medial temporal tau and neocortical tau). Here, MAPT is linked to Alzheimer disease.